agonistic anti icos antibody (Jounce Therapeutics)
86
Structured Review
Jounce Therapeutics
agonistic anti icos antibody
Agonistic Anti Icos Antibody, supplied by Jounce Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agonistic+anti+icos+antibody/agonistic+anti+antibody+icos/us12655159-876-33-30
Average 86 stars, based on 1 article reviews
Agonistic Anti Icos Antibody, supplied by Jounce Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agonistic+anti+icos+antibody/agonistic+anti+antibody+icos/us12655159-876-33-30
Average 86 stars, based on 1 article reviews
agonistic anti icos antibody - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Deuterated IRAK degraders and uses thereof Article Snippet: CD27 agonists that are being studied in clinical trials include varlilumab (CDX-1127, Celldex Therapeutics) an agonistic anti-CD27 antibody, in squamous cell head and neck cancer, ovarian carcinoma, colorectal cancer, renal cell cancer, and glioblastoma (NCT02335918); lymphomas (NCT01460134); and glioma and astrocytoma (NCT02924038). Clinical Proteomics:Article Title: GPR84 antagonists and uses thereof Article Snippet: .. ICOS agonists that are being studied in clinical trials include MEDI-570 (Medimmune), an agonistic anti-ICOS antibody, in lymphomas (NCT02520791); GSK3359609 (Merck), an agonistic anti-ICOS antibody, in Phase 1 (NCT02723955); |